Newspaper Advertisement of Financial Results under Regulation 47 of SEBI (LODR), 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek Ltd has submitted newspaper clippings of its audited financial results for the quarter and year ended March 31, 2025, as required under Regulation 47 of SEBI (LODR) Regulations, 2015. The results were published in Business Standard (English) and Navatelangana (Telugu) newspapers on May 9, 2025. The board had approved these results at its meeting held on May 8, 2025. The letter was signed by Dr K Koteswara Rao, Chairman & Managing Director. No specific financial figures for Transgene Biotek are included in this filing — it is purely a compliance submission confirming that the published advertisements were filed with BSE.
This is a routine regulatory compliance filing with no material business or price impact. It simply confirms that the company's audited FY25 results were published in newspapers and submitted to BSE as mandated.